- Exchange: NASDAQ CM
- Sector: Health Care
- Industry: Biotech & Pharma
- Sub-Industry: Specialty Pharmaceuticals
Insmed Inc+ Add to Watchlist
INSM:US16.1500 USD 0.7800 4.61%
As of 10:46:55 ET on 12/06/2013.
Company Profile for Insmed Inc (INSM)
Insmed, Inc. is a biopharmaceutical company focused on developing and commercializing novel, targeted inhaled therapies for patients with high unmet need battling serious orphan lung diseases.
Key Executives for Insmed Inc (INSM)
|William H Lewis "Will"President/CEO||Andrew T DrechslerChief Financial Officer|
|Matthew PaulsChief Commercial Officer||Renu GuptaExec VP:Dev/Chief Medical Ofcr|
|Christine A PellizzariSecretary/General Counsel|